Skip to main
A

Agilent Technologies (A) Stock Forecast & Price Target

Agilent Technologies (A) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 47%
Hold 12%
Sell 0%
Strong Sell 0%

Bulls say

Agilent Technologies is well positioned because its Q3 organic sales growth of 7.3% exceeded expectations, with Life Sciences and Diagnostics up about 10% organically and pharma-related revenue up 9% even excluding CDMO strength. Its outlook is supported by synchronized product cycles across LC, GC, and ICP-MS, plus broad exposure to sticky end markets such as biopharma and chemical/advanced materials, which both showed strong growth and are benefiting from reshoring demand. The company also has a favorable mix of recurring consumables and services, a geographically diverse footprint, and improving margins under IGNITE, suggesting durable revenue momentum and earnings leverage.

Bears say

Agilent Technologies is viewed negatively because its revenue mix is unusually exposed to cyclical end markets, with about 25% from chemical and advanced materials and another 10% from environmental/forensics, making demand vulnerable to macroeconomic deterioration and industrial softness. The company is also more exposed to China than peers, deriving 18% of sales there versus roughly 12% for the peer average, while mixed China conditions and competitive pressure could weigh on growth durability and pricing. Even though the FQ3 core growth guide of 4.4%-5.9% and $1.83B-$1.85B revenue suggests modest progress, flat sequential EBIT, EPS of $1.48-$1.50, and only 80 bps of expected EBIT expansion leave limited room for margin upside, tariffs, phasing, and other execution risks.

Agilent Technologies (A) has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 47% recommend Buy, 12% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Agilent Technologies and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Agilent Technologies (A) Forecast

Analysts have given Agilent Technologies (A) a Buy based on their latest research and market trends.

According to 17 analysts, Agilent Technologies (A) has a Buy consensus rating as of Oct 4, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $174.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $174.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Agilent Technologies (A)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.